dioxolanes - CISMeF

Preferred Label : dioxolanes;

Wikipedia link : https://en.wikipedia.org/wiki/Dioxolanes;

Is substance : O;

Details

Origin ID

D004148;

UMLS CUI

C0012504;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 1,3-dioxolane [Substance BNPC]
- Dioxolane (substance) [SNOMED CT concept]
Record concept(s)
- dioxolanes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1-(2,2-diphenyl-(1,3)dioxolan-4-yl)-ethyl)-dimethyl-amine [MeSH Supplementary Concept]
- (2R,4S)-2-(2-(4-chlorophenyl)ethyl)-2-((1H-imidazol-1-yl)methyl)-4(((5-trifluoromethylpyridin-2-yl)thio)methyl)-1,3-dioxolane [MeSH Supplementary Concept]
- (4-2-aminopurin-9-yl)-1,3-dioxolane-2-methanol [MeSH Supplementary Concept]
- (4R,5S,alpha'R)-2,2-dimethyl-alpha,alpha,alpha'-tris(perfluorooctyl)-2,3-dioxolane-4,5-dimethanol [MeSH Supplementary Concept]
- (4S,5S)-2,2,4-triethyl-5-methyl-1,3-dioxolane [MeSH Supplementary Concept]
- 1'-sulfoxymyristicin [MeSH Supplementary Concept]
- 1,3-dioxolium-4-olate [MeSH Supplementary Concept]
- 1-(2-(hydroxymethyl)-1,3-dioxolan-5-yl)-5-(2-iodovinyl)uracil [MeSH Supplementary Concept]
- 1-(5-(2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl))uracil [MeSH Supplementary Concept]
- 2'-methylspiro-(1-azabicyclo(2.2.2.)octane-3,4'-(1,3)-dioxolane) [MeSH Supplementary Concept]
- 2,2-dimethyl-1,3-dioxolane-4-methanol [MeSH Supplementary Concept]
- 2,2-dinaphthalen-2-yl-(1,3)dioxolane-4,5-dicarboxylic acid [MeSH Supplementary Concept]
- 2,2-diphenyl-(1,3)-dioxolan-4-ylmethyl(dimethyl)amine methiodide [MeSH Supplementary Concept]
- 2,2-diphenyl-(1,3)dioxolane-4,5-dicarboxylic acid [MeSH Supplementary Concept]
- 2,5-bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane [MeSH Supplementary Concept]
- 2-(2-(4-chlorophenyl)ethyl)-2-((1H-imidazol-1-yl)methyl)-4-methyl-1,3-dioxolane [MeSH Supplementary Concept]
- 2-(3-(1,3)-dioxolan-2-ylpropyl)-2-oxazoline [MeSH Supplementary Concept]
- 2-(5-nitrofuran-2-yl)-4-phenyl-1,3-dioxolane [MeSH Supplementary Concept]
- 2-bromomethyl-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl [MeSH Supplementary Concept]
- 2-ethoxy-(1,3)dioxolane-4,5-dicarboyxlic acid diethyl ester [MeSH Supplementary Concept]
- 2-ethyl-4-methyl-1,3-dioxolane [MeSH Supplementary Concept]
- 2-hexyl-1,3-dioxolane [MeSH Supplementary Concept]
- 2-methyldioxolane [MeSH Supplementary Concept]
- 2-n-nonyl-1,3-dioxolane [MeSH Supplementary Concept]
- 2-sec-butoxy-6,6-dichloro-1,4-dioxolan-5-one [MeSH Supplementary Concept]
- 20-hydroxyecdysone dioxolane [MeSH Supplementary Concept]
- 2RS, 4RS-1-(2-(4-chlorophenyl)-4-(2-(2-ethoxyphenyl)-ethyl)-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-triazole [MeSH Supplementary Concept]
- 2RS,4RS-1-(2-phenyl-4-(2-(2-trifluromethoxy-phenoxy)-ethyl)-1,3-dioxolan-2-yl-methyl)-1H-1,2,4-triazole [MeSH Supplementary Concept]
- 3,4-methylenedioxy-beta-nitrostyrene [MeSH Supplementary Concept]
- 3,7-dimethyl-9-(-2,2,5,5-tetramethyl-1,3-dioxolan-4-yl)nona-1,6-dien-3-ol [MeSH Supplementary Concept]
- 4'-(4,5-dimethyl-1,3-dioxolan-2-yl)methylphenol [MeSH Supplementary Concept]
- 4,5-dichloro-1,2-methylenedioxybenzene [MeSH Supplementary Concept]
- 4,5-dichloro-1,3-dioxolan-2-one [MeSH Supplementary Concept]
- 4-((6,7-epoxy-3-ethyl-7-methyl-2-nonenyl)oxy)-1,2- (methylenedioxy)benzene [MeSH Supplementary Concept]
- 4-(2-(2-methoxyphenoxy)ethylaminomethyl)-2,2-diphenyl(1,3)dioxolane [MeSH Supplementary Concept]
- 4-(2-amino-6-chloro-9H-purin-9-yl)-1,3-dioxolane-2-methanol [MeSH Supplementary Concept]
- 4-(2-phenoxyethylaminomethyl)-2,2-diphenyl(1,3)dioxolane [MeSH Supplementary Concept]
- 4-(hydroxymethyl)-2-pentadecyl-1,3-dioxolane [MeSH Supplementary Concept]
- 4-butyldioxolane [MeSH Supplementary Concept]
- 4-hydroxy-5-hydroxymethyl-(1,3)dioxolan-2,6'-spirane-5',6',7',8'-tetrahydro-indolizine-3'-carbaldehyde [MeSH Supplementary Concept]
- 4-hydroxymethyl-1,3-dioxolan-2-one [MeSH Supplementary Concept]
- 4-methoxy-9-(3,4,5-trimethoxyphenyl)-8,9-dihydrofuro(3',4':6,7)naphtho(2,3-d)(1,3)dioxol-6(5H)-one [MeSH Supplementary Concept]
- 4-methyl-1,3-dioxolan-2-one [MeSH Supplementary Concept]
- 4-methyl-1,3-dioxolan-2-one and 4,5-dichloro-1,3-dioxolan-2-one [MeSH Supplementary Concept]
- 5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro(2,3-d)(1,3)dioxol-6-yl(3-(tritriethoxysilyl) [MeSH Supplementary Concept]
- 5-(2-bromovinyl)-1-(2-(hydroxymethyl)-1,3-dioxolan-5-yl)uracil [MeSH Supplementary Concept]
- 5-(2-chlorovinyl)-1-(2-(hydroxymethyl)-1,3-dioxolan-5-yl)uracil [MeSH Supplementary Concept]
- 5-fluoro-1-(2-(hydroxymethyl)-1,3-dioxolan-4-yl)cytosine [MeSH Supplementary Concept]
- 5-hydroxylpiperlongumine [MeSH Supplementary Concept]
- 5-iododioxolane uracil [MeSH Supplementary Concept]
- 5-methoxyjusticidin A [MeSH Supplementary Concept]
- 9-(((2-ethyl(1,3)dioxolan-4-yl)guanine))phosphonic acid [MeSH Supplementary Concept]
- 9-(1,3-dioxolan-4-yl)guanine [MeSH Supplementary Concept]
- 9-methoxystrobilurin E [MeSH Supplementary Concept]
- 9-methoxystrobilurin L [MeSH Supplementary Concept]
- AY 22352 [MeSH Supplementary Concept]
- BN 52111 [MeSH Supplementary Concept]
- BN 52115 [MeSH Supplementary Concept]
- N-((4-methyl-5-methylene-2-oxo-1,3-dioxolan-4-yl)oxy)norfloxacin [MeSH Supplementary Concept]
- N-methylactinodaphnine [MeSH Supplementary Concept]
- SDZ 51641 [MeSH Supplementary Concept]
- SWR 104SA [MeSH Supplementary Concept]
- actinodaphine [MeSH Supplementary Concept]
- alpha,alpha,alpha',alpha'-tetraaryl-1,3-dioxolane-4,5-dimethanol [MeSH Supplementary Concept]
- alpha-methyl-3,4-methylene-dioxyhydrocinnamic aldehyde [MeSH Supplementary Concept]
- amdoxovir [MeSH Supplementary Concept]
- aminocarbene [MeSH Supplementary Concept]
- combretadioxolane [MeSH Supplementary Concept]
- cyclonium [MeSH Supplementary Concept]
- dexoxadrol [MeSH Supplementary Concept]
- difenoconazole [MeSH Supplementary Concept]
- dihydrocubebin [MeSH Supplementary Concept]
- dihydromyristicin [MeSH Supplementary Concept]
- dioxadrol [MeSH Supplementary Concept]
- dioxolamycin [MeSH Supplementary Concept]
- dioxolane guanosine [MeSH Supplementary Concept]
- dioxolane guanosine 5'-triphosphate [MeSH Supplementary Concept]
- dioxolane-thymine [MeSH Supplementary Concept]
- dioxonium [MeSH Supplementary Concept]
- dioxychlorane [MeSH Supplementary Concept]
- dioxyflurane [MeSH Supplementary Concept]
- diphyllin acetyl apioside [MeSH Supplementary Concept]
- domiodol [MeSH Supplementary Concept]
- erbulozole [MeSH Supplementary Concept]
- ethyl 2-((((4-(2-amino-6-hydroxy-9H-purin-9-yl)-1,3-dioxolan-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate [MeSH Supplementary Concept]
- ethylene carbonate [MeSH Supplementary Concept]
- etoxadrol [MeSH Supplementary Concept]
- etoxadrol-2-isothiocyanate [MeSH Supplementary Concept]
- formal glycol [MeSH Supplementary Concept]
- furolan [MeSH Supplementary Concept]
- genkdaphine [MeSH Supplementary Concept]
- glycerol formal [MeSH Supplementary Concept]
- guignardic acid [MeSH Supplementary Concept]
- justicidins [MeSH Supplementary Concept]
- levoxadrol [MeSH Supplementary Concept]
- methamilane methiodide [MeSH Supplementary Concept]
- methyl piperonylate [MeSH Supplementary Concept]
- methylpiperate [MeSH Supplementary Concept]
- multistriatin [MeSH Supplementary Concept]
- myristicin [MeSH Supplementary Concept]
- naphthyl-TADDOL [MeSH Supplementary Concept]
- okoumal [MeSH Supplementary Concept]
- otobanone [MeSH Supplementary Concept]
- oudemansin L [MeSH Supplementary Concept]
- perfluoro-2,2,2',2'-tetramethyl-4,4'-bis(1,3-dioxolane) [MeSH Supplementary Concept]
- phenguignardic acid [MeSH Supplementary Concept]
- pilosinine [MeSH Supplementary Concept]
- piperlongumine [MeSH Supplementary Concept]
- pipoxolan [MeSH Supplementary Concept]
- plakinic acid A [MeSH Supplementary Concept]
- propyl isome [MeSH Supplementary Concept]
- protokylol [MeSH Supplementary Concept]
- prulifloxacin [MeSH Supplementary Concept]
- ramontoside [MeSH Supplementary Concept]
- rimboxo [MeSH Supplementary Concept]
- sarisan [MeSH Supplementary Concept]
- sch 31828 [MeSH Supplementary Concept]
- sch 34826 [MeSH Supplementary Concept]
- seletinoid G [MeSH Supplementary Concept]
- sodium 4-((2-methyl-2-undecyl-1,3-dioxolan-4-yl)methoxyl)-1-propanesulfonate [MeSH Supplementary Concept]
- stiripentol [MeSH Supplementary Concept]
- stolonoxide C methyl ester [MeSH Supplementary Concept]
- stolonoxide E [MeSH Supplementary Concept]
- stolonoxide F [MeSH Supplementary Concept]
- thermalic acid A [MeSH Supplementary Concept]
- thermalic acid B [MeSH Supplementary Concept]
- trans-dimethyl tartrate acetonide [MeSH Supplementary Concept]
- troxacitabine [MeSH Supplementary Concept]
- tuberculatin [MeSH Supplementary Concept]
- tubulazole [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients